Dual immune checkpoint blockade for non-small cell lung cancer patients with PD-L1 high expression: calling an end?

ABSTRACT:

SUBMITTER: Peng L 

PROVIDER: S-EPMC8512471 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature